Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2007
11/15/2007WO2007130882A2 Method for treatment of diarrhea-predominant irritable bowel syndrome
11/15/2007WO2007130860A2 Constrained compounds as cgrp-receptor antagonists
11/15/2007WO2007130825A2 Fused heterocyclic compounds and their use as mglur5 modulators
11/15/2007WO2007130823A2 Polycyclic heterocyclic compounds and their use as modulators of the metabotropic glutamate 5 receptor
11/15/2007WO2007130822A2 Mglur5 modulators iii
11/15/2007WO2007130814A1 Crystalline (3-cyano-1h-indol-7-yl)-[4-(4-fluorophenethyl)piperazin-1-yl]methanone phosphate
11/15/2007WO2007130783A2 Metabolically stable alkoxyalkyl esters of antiviral or antiproliferative phosphonates, nucleoside phosphonates and nucleoside phosphates
11/15/2007WO2007130780A2 Benzimidazole modulators of vr1
11/15/2007WO2007130738A1 Anti-herpes virus properties of various forms of sophorolipids
11/15/2007WO2007130713A1 Novel fenofibrate formulations and related methods of treatment
11/15/2007WO2007130712A1 Substituted dipiperidine as ccr2 antagonists for the treatment of inflammatory diseases
11/15/2007WO2007130626A2 Bivalent smac mimetics and the uses thereof
11/15/2007WO2007130616A2 Polyamides for treating human papilloma virus
11/15/2007WO2007130589A2 Nl, n4-bis (buta-i, 3-dienyl) butane-i, 4-diamine pharmaceutical compositions and uses thereof
11/15/2007WO2007130509A2 Pyrroloquinoline quinones and use thereof
11/15/2007WO2007130507A2 Acute pain medications based on fast acting diclofenac-opioid combinations
11/15/2007WO2007130499A2 Antiviral agents
11/15/2007WO2007130477A2 Delivery of ophthalmologic agents to the exterior or interior of the eye
11/15/2007WO2007130468A2 Pyrido [2, 3-b] pyrazine and [1, 8] -naphthyridine derivatives as alk and c-met inhibitors
11/15/2007WO2007130429A2 Histone deacetylase and tubulin deacetylase inhibitors
11/15/2007WO2007130419A2 Histone deacetylase inhibitors for the treatment of neurodegeneration
11/15/2007WO2007130404A1 Methods of using [3.2.0] heterocyclic compounds and analogs thereof for the treatment of lung cancer
11/15/2007WO2007130383A2 Compositions and treatments using pyridazine compounds and secretases
11/15/2007WO2007130373A2 Novel triptan formulations and methods for making them
11/15/2007WO2007130364A2 Compositions, methods, and kits for treating dry eye
11/15/2007WO2007130134A2 Controlled release microparticles
11/15/2007WO2007130124A1 Treating cancer with cardiac glycosides
11/15/2007WO2007130113A2 Parathyroid hormone analogues and methods of use
11/15/2007WO2007130075A1 Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
11/15/2007WO2007130037A1 Hif-1 inhibitors and methods of use thereof
11/15/2007WO2007129963A1 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129962A1 2-pyridone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
11/15/2007WO2007129961A1 Parenteral formulation comprising proton pump inhibitor sterilized in its final container by ionizing radiation
11/15/2007WO2007129879A1 THE USE OF NICOTINE, ANALOGUES THEREOF, PRECURSORS THEREOF OR DERIVATIVES THEREOF IN THE TREATMENT OF VARIOUS PATHOLOGICAL PROCESSES CAPABLE OF IMPROVEMENT WITH a-MSH ADMINISTERED IN PROPHYLACTIC OR THERAPEUTIC FORM
11/15/2007WO2007129745A1 Heteroarylamide lower carboxylic acid derivative
11/15/2007WO2007129743A1 Anti-inflammatory composition
11/15/2007WO2007129729A1 Process for production of fish-derived ceramide, and ceramide-containing composition
11/15/2007WO2007129725A1 Agent for preventing liver disease
11/15/2007WO2007129712A1 Transdermally absorbable donepezil preparation
11/15/2007WO2007129668A1 Pyrazolyl 5-thioglucoside compound
11/15/2007WO2007129646A1 Macrolide derivative
11/15/2007WO2007129618A1 Inhibitor of neutrophil activation/migration factor and use thereof
11/15/2007WO2007129522A1 Preparation produced by dry process
11/15/2007WO2007129487A1 Livestock feed
11/15/2007WO2007129473A1 Bicyclic aryl derivative
11/15/2007WO2007129439A1 Inhibitor of increase in postprandial blood insulin level
11/15/2007WO2007129427A1 Tansdermally absorbable preparation comprising anti-dementia agent
11/15/2007WO2007129406A1 Degranulation inhibitor
11/15/2007WO2007129329A2 Extended release pharmaceutical formulation comprising venlafaxine hydrochloride
11/15/2007WO2007129290A1 Statins for the treatment of viral influenza infections
11/15/2007WO2007129188A1 Cyclopropanecarboxamide compound
11/15/2007WO2007129176A2 Improvements in therapy for treating resistant bacterial infections
11/15/2007WO2007129169A2 Cox- ii inhibitors for improving reproductive success in a female animal
11/15/2007WO2007129162A2 Pharmaceutical preparations for transdermal use
11/15/2007WO2007129119A1 Pentacyclic indole derivatives as antiviral agents
11/15/2007WO2007129114A2 Aptamers directed to recombinant muc1
11/15/2007WO2007129111A1 Diazepine derivatives as 5-ht2a antagonists
11/15/2007WO2007129083A1 Anti-viral pyrimidine nucleoside derivatives
11/15/2007WO2007129066A1 4- (2,6-dichloro-benzoylamino) -1h-pyrazole-3-carboxylic acid (1-methanesulphonyl-piperidin-4-yl) -amide for the treatment of cancer
11/15/2007WO2007129062A1 Pharmaceutical combinations of diazole derivatives for cancer treatment
11/15/2007WO2007129060A1 Tetrahydropyrrolopyrimidinediones and their use as human neutrophil elastase inhibitors
11/15/2007WO2007129053A1 Methods of diagnosis and treatment of equine laminitis and cushing' s syndrome
11/15/2007WO2007129052A1 Pyrazole derivatives and their use as pi3k inhibitors
11/15/2007WO2007129048A1 Thiazole derivatives as inhibitors of p13 kinase
11/15/2007WO2007129044A1 Thiazole derivatives and their use as anti-tumour agents
11/15/2007WO2007129040A1 p38 MAP KINASE INHIBITORS
11/15/2007WO2007129036A1 Inhibitors of p38 map kinase
11/15/2007WO2007129020A1 Pyrimidine derivatives useful as dhfr inhibitors
11/15/2007WO2007129019A1 Sulfonamide compounds useful as edg receptor modulators
11/15/2007WO2007129005A1 Aminoacid derivatives of thiazoles as inhibitors of pi3 kinase
11/15/2007WO2007128987A2 Therapy targeting cathepsin s
11/15/2007WO2007128968A1 Telomerase inhibitors
11/15/2007WO2007128914A1 Novel drugs for anti-herpes virus treatments
11/15/2007WO2007128884A1 Novel genes and markers in type 2 diabetes and obesity
11/15/2007WO2007128840A2 Use of troxerutin to quench the fluorescence of disodium phenyl dibenzimidazole tetrasulfonate
11/15/2007WO2007128829A2 18,21-didesoxymacbecin derivatives for the treatment of cancer
11/15/2007WO2007128827A1 17-oxymacbecin derivatives and their use in the treatment of cancer and/or b-cell malignancies
11/15/2007WO2007128820A1 Combination comprising an iron chelator and an anti-neoplastic agent and use thereof
11/15/2007WO2007128802A2 Use of flibanserin for the treatment of post-menopausal sexual desire disorders
11/15/2007WO2007128801A1 Combination of organic compounds
11/15/2007WO2007128782A1 Spiro- (tho) benzopyran-2, 4' -piperidine-and cyclohexane derivatives as inhibitors of specific cell cycle enzymes
11/15/2007WO2007128761A2 Uses of dpp-iv inhibitors
11/15/2007WO2007128752A1 Pyridyl compounds
11/15/2007WO2007128749A1 Glucopyranosyl-substituted benzonitrile derivatives, pharmaceutical compositions containing such compounds, their use and process for their manufacture
11/15/2007WO2007128725A1 6h-benzofuro[3,2-c] [1]benzopyran and [2] benzopyrano [4,3-b] [1]benzopyran derivatives and wood extracts of these compounds as aryl hydrocarbon receptor (ahr) antagonists for the prevention of uv-b induced skin damage
11/15/2007WO2007128723A1 Ah receptor antagonists
11/15/2007WO2007128721A1 Polymorphs
11/15/2007WO2007128694A1 N-oxides of pyridylmethylpiperazine and -piperidine derivatives
11/15/2007WO2007128674A2 Muscarinic agonists to treat impulse control disorders
11/15/2007WO2007128588A2 Glutadon
11/15/2007WO2007128568A1 Bicyclic derivatives as cetp inhibitors
11/15/2007WO2007128564A2 Use of a compound with rankl activity
11/15/2007WO2007128561A1 Crystalline forms of letrozole and processes for making them
11/15/2007WO2007128538A1 5-urea substituted naphthalimide derivatives, methods of production and pharmaceutical compositions for treating cancer
11/15/2007WO2007128537A2 Pharmaceutical preparation based on myrtucommulone a for the selective tumour and cancer therapy
11/15/2007WO2007128492A1 Novel pharmaceutical compositions
11/15/2007WO2007128482A1 Use of a b-cell-depleting antibody for treatment of polyoma virus infections
11/15/2007WO2007128480A2 Thioglycosides as pharmaceutically active agents
11/15/2007WO2007128478A2 Pharmaceutical composition
11/15/2007WO2007128476A1 Pharmaceutical compositions containing clopidogrel hydrochloride
1 ... 3498 3499 3500 3501 3502 3503 3504 3505 3506 3507 3508 3509 3510 3511 3512 3513 3514 3515 3516 3517 3518 ... 7860